Deferasirox in thalassemia: a comparative study between an innovator drug and its copy among a sample of Iraqi patients [PDF]
, 2019 Aqil Mohammad Daher +2 more
openalex +1 more source
Allogeneic hematopoietic cell transplantation rescues congenital red cell aplasia in H syndrome due to <i>SLC29A3</i> mutations. [PDF]
HaematologicaQuigg TC +4 more
europepmc +1 more source
Glycosidase-activated prodrugs of a cytotoxic iron chelator for targeted cancer therapy. [PDF]
RSC Med ChemTomar D +5 more
europepmc +1 more source
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk
, 2018 Norbert Gattermann +8 more
openalex +1 more source
Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites. [PDF]
ACS Infect DisMalych R +18 more
europepmc +1 more source
A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori. [PDF]
PLoS OneIshii M +4 more
europepmc +1 more source
Combination of a triple alpha-globin gene with beta-thalassemia in a gypsy family: importance of the genetic testing in the diagnosis and search for a donor for bone marrow transplantation for one of their children [PDF]
, 2016 Carmen Rodriguez-Vigil Iturrate +4 more
core +1 more source
Luspatercept for the treatment of transfusion-dependent non-severe aplastic anemia. [PDF]
Ann HematolJia X +7 more
europepmc +1 more source
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics [PDF]
, 2015 core +1 more source